NCT07714889Withdrawn
Development of an Accessible Cognitive Behavioral Therapy Digital Therapeutic for Individuals With Long COVID
Source: ClinicalTrials.gov · Last updated 29 Jul 2026
Reason given: This study does not meet the clinical trial definition under FDAAA 801 / NIH policy - participants aren't prospectively assigned to an intervention, and no biomedical or behavioral outcome is evaluated.
Brief summary (registry, in English)
This study will evaluate Toivoa-004 as an experimental digital therapeutic for persons with Long COVID suffering from anxiety or depression. This study will evaluate the completion rates of the Toivoa-004 program and survey the user's experience upon completion. Changes in anxiety and depression scores will be monitored during the study.
- Status (registry)
- Withdrawn
- Study type
- Interventional
- Enrollment
- 0 (actual)
- First submitted
- 1 Jul 2026
- Start date
- Jul 2026
- Primary completion date
- Sept 2026
- Lead sponsor
- Toivoa Inc
- Diseases
- Long COVID and ME/CFS
- NCT number
- NCT07714889
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Self-reported substance use disorder. In the past 12 months (not including tobacco).
Other
- Self-reported suicide attempts in the past year or elevated suicide risk other than passive ideation (i.e., endorsing items reflecting intent, identifying means, suicide planning, or suicide-related preparations).
- Currently pregnant or planning to become pregnant during the treatment period.
Who the study is looking for
- Provision of signed and dated informed consent form.
- Presence of clinically diagnosed Long COVID.
- Stated willingness to comply with all study procedures and lifestyle considerations, and availability for the duration of the study.
- Males and females; Age 22 and above.
- Clinical Diagnosis of Long COVID
- Willingness to adhere to the study regiment.
- Access to necessary resources for participating in a technology-based intervention (i.e., Phone, internet access).
- Able to read and speak English fluently.
- Resident of the US and living in the US for the duration of the study.
- __________________________
Age in the registry: 22 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.